264 related articles for article (PubMed ID: 27313454)
1. Pericyte-targeting drug delivery and tissue engineering.
Kang E; Shin JW
Int J Nanomedicine; 2016; 11():2397-406. PubMed ID: 27313454
[TBL] [Abstract][Full Text] [Related]
2. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
[TBL] [Abstract][Full Text] [Related]
3. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
[TBL] [Abstract][Full Text] [Related]
4. Targeting pericytes for angiogenic therapies.
Kelly-Goss MR; Sweat RS; Stapor PC; Peirce SM; Murfee WL
Microcirculation; 2014 May; 21(4):345-57. PubMed ID: 24267154
[TBL] [Abstract][Full Text] [Related]
5. Pericytes: a double-edged sword in cancer therapy.
Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
[TBL] [Abstract][Full Text] [Related]
6. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
[TBL] [Abstract][Full Text] [Related]
8. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth.
Thijssen VL; Paulis YW; Nowak-Sliwinska P; Deumelandt KL; Hosaka K; Soetekouw PM; Cimpean AM; Raica M; Pauwels P; van den Oord JJ; Tjan-Heijnen VC; Hendrix MJ; Heldin CH; Cao Y; Griffioen AW
J Pathol; 2018 Dec; 246(4):447-458. PubMed ID: 30101525
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
10. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche.
Díaz-Flores L; Gutiérrez R; Madrid JF; Varela H; Valladares F; Acosta E; Martín-Vasallo P; Díaz-Flores L
Histol Histopathol; 2009 Jul; 24(7):909-69. PubMed ID: 19475537
[TBL] [Abstract][Full Text] [Related]
11. Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.
Miljkovic-Licina M; Hammel P; Garrido-Urbani S; Lee BP; Meguenani M; Chaabane C; Bochaton-Piallat ML; Imhof BA
Mol Cancer Ther; 2012 Dec; 11(12):2588-99. PubMed ID: 23002094
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous fibroblast-derived pericyte recruitment in a human tissue-engineered angiogenesis model in vitro.
Berthod F; Symes J; Tremblay N; Medin JA; Auger FA
J Cell Physiol; 2012 May; 227(5):2130-7. PubMed ID: 21769871
[TBL] [Abstract][Full Text] [Related]
13. Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering.
Campagnolo P; Gormley AJ; Chow LW; Guex AG; Parmar PA; Puetzer JL; Steele JA; Breant A; Madeddu P; Stevens MM
Adv Healthc Mater; 2016 Dec; 5(23):3046-3055. PubMed ID: 27782370
[TBL] [Abstract][Full Text] [Related]
14. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Raza A; Franklin MJ; Dudek AZ
Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
[TBL] [Abstract][Full Text] [Related]
15. Pericytes enable effective angiogenesis in the presence of proinflammatory signals.
Kang TY; Bocci F; Jolly MK; Levine H; Onuchic JN; Levchenko A
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23551-23561. PubMed ID: 31685607
[TBL] [Abstract][Full Text] [Related]
16. Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity.
Hoffmann J; Feng Y; vom Hagen F; Hillenbrand A; Lin J; Erber R; Vajkoczy P; Gourzoulidou E; Waldmann H; Giannis A; Wolburg H; Shani M; Jaeger V; Weich HA; Preissner KT; Hoffmann S; Deutsch U; Hammes HP
FASEB J; 2005 Dec; 19(14):2035-6. PubMed ID: 16215210
[TBL] [Abstract][Full Text] [Related]
17. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
Keskin D; Kim J; Cooke VG; Wu CC; Sugimoto H; Gu C; De Palma M; Kalluri R; LeBleu VS
Cell Rep; 2015 Feb; 10(7):1066-81. PubMed ID: 25704811
[TBL] [Abstract][Full Text] [Related]
18. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-Kinase-Regulated Pericyte Maturation Governs Vascular Remodeling.
Figueiredo AM; Villacampa P; Diéguez-Hurtado R; José Lozano J; Kobialka P; Cortazar AR; Martinez-Romero A; Angulo-Urarte A; Franco CA; Claret M; Aransay AM; Adams RH; Carracedo A; Graupera M
Circulation; 2020 Aug; 142(7):688-704. PubMed ID: 32466671
[TBL] [Abstract][Full Text] [Related]
20. Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy.
Chen Z; Xu XH; Hu J
Neoplasma; 2016; 63(2):173-82. PubMed ID: 26774138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
